Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biomarkers, Tumor | 6 | 2017 | 409 | 1.540 |
Why?
|
| Lung Neoplasms | 4 | 2017 | 357 | 1.260 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2017 | 105 | 1.190 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 12 | 2020 | 72 | 1.130 |
Why?
|
| Adenocarcinoma | 4 | 2017 | 300 | 1.090 |
Why?
|
| Tandem Mass Spectrometry | 6 | 2024 | 115 | 1.040 |
Why?
|
| Pancreatic Neoplasms | 5 | 2015 | 546 | 0.890 |
Why?
|
| Serum | 3 | 2024 | 11 | 0.860 |
Why?
|
| Proteomics | 2 | 2017 | 192 | 0.850 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2017 | 163 | 0.800 |
Why?
|
| Diabetic Angiopathies | 1 | 2020 | 48 | 0.650 |
Why?
|
| Early Detection of Cancer | 4 | 2015 | 132 | 0.600 |
Why?
|
| Diagnosis, Differential | 8 | 2020 | 378 | 0.590 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 218 | 0.550 |
Why?
|
| Neurocysticercosis | 3 | 2024 | 14 | 0.530 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 340 | 0.500 |
Why?
|
| Neoplasm Staging | 7 | 2017 | 478 | 0.500 |
Why?
|
| Aged, 80 and over | 7 | 2017 | 2045 | 0.500 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2015 | 144 | 0.490 |
Why?
|
| Middle Aged | 14 | 2024 | 7310 | 0.490 |
Why?
|
| Aged | 10 | 2020 | 5525 | 0.460 |
Why?
|
| Pancreatitis, Chronic | 1 | 2015 | 7 | 0.460 |
Why?
|
| Case-Control Studies | 5 | 2020 | 732 | 0.440 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2014 | 2 | 0.430 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2014 | 5 | 0.430 |
Why?
|
| Adult | 13 | 2024 | 7922 | 0.400 |
Why?
|
| Female | 19 | 2024 | 15471 | 0.400 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 61 | 0.400 |
Why?
|
| Hydrocarbons | 2 | 2010 | 41 | 0.380 |
Why?
|
| Listeriosis | 1 | 2012 | 41 | 0.380 |
Why?
|
| Predictive Value of Tests | 4 | 2017 | 480 | 0.380 |
Why?
|
| Listeria monocytogenes | 1 | 2012 | 59 | 0.370 |
Why?
|
| Male | 15 | 2024 | 13771 | 0.370 |
Why?
|
| Humans | 20 | 2024 | 28581 | 0.310 |
Why?
|
| Phenotype | 2 | 2020 | 682 | 0.260 |
Why?
|
| Zinc Fingers | 5 | 2008 | 26 | 0.250 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 595 | 0.230 |
Why?
|
| Taenia solium | 1 | 2024 | 4 | 0.220 |
Why?
|
| Helminth Proteins | 1 | 2024 | 19 | 0.220 |
Why?
|
| Mass Spectrometry | 3 | 2024 | 191 | 0.220 |
Why?
|
| Animals | 13 | 2024 | 10580 | 0.200 |
Why?
|
| Retrospective Studies | 3 | 2020 | 2612 | 0.190 |
Why?
|
| Epilepsy | 2 | 2020 | 37 | 0.180 |
Why?
|
| Epilepsy, Generalized | 1 | 2020 | 2 | 0.170 |
Why?
|
| Systems Biology | 1 | 2020 | 22 | 0.170 |
Why?
|
| Blood Proteins | 1 | 2020 | 68 | 0.160 |
Why?
|
| Endometrial Neoplasms | 1 | 2022 | 189 | 0.160 |
Why?
|
| Biomarkers | 2 | 2020 | 770 | 0.160 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 68 | 0.160 |
Why?
|
| War-Related Injuries | 1 | 2019 | 2 | 0.150 |
Why?
|
| Post-Concussion Syndrome | 1 | 2019 | 4 | 0.150 |
Why?
|
| Migraine Disorders | 1 | 2019 | 22 | 0.150 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2019 | 41 | 0.150 |
Why?
|
| Transcription Factors | 5 | 2008 | 523 | 0.150 |
Why?
|
| Veterans | 1 | 2019 | 69 | 0.140 |
Why?
|
| Databases, Protein | 1 | 2017 | 22 | 0.140 |
Why?
|
| Cell Adhesion | 1 | 2017 | 139 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2017 | 90 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 988 | 0.130 |
Why?
|
| Sodium Selenite | 2 | 2008 | 4 | 0.130 |
Why?
|
| Computational Biology | 1 | 2017 | 156 | 0.120 |
Why?
|
| Mice | 4 | 2015 | 4732 | 0.120 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2015 | 25 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 524 | 0.110 |
Why?
|
| Pancreas | 1 | 2015 | 63 | 0.110 |
Why?
|
| Transcription Factor TFIIIA | 5 | 2008 | 12 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2014 | 110 | 0.100 |
Why?
|
| Biopsy | 1 | 2014 | 207 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2013 | 58 | 0.100 |
Why?
|
| Sp1 Transcription Factor | 4 | 2008 | 17 | 0.100 |
Why?
|
| DNA | 3 | 2008 | 375 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 285 | 0.090 |
Why?
|
| DNA-Binding Proteins | 4 | 2005 | 490 | 0.090 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 509 | 0.090 |
Why?
|
| Disease-Free Survival | 1 | 2011 | 236 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 478 | 0.090 |
Why?
|
| ROC Curve | 1 | 2011 | 144 | 0.090 |
Why?
|
| Rats | 3 | 2010 | 1587 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 554 | 0.080 |
Why?
|
| Inhalation Exposure | 1 | 2010 | 15 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2011 | 209 | 0.080 |
Why?
|
| Mutation | 1 | 2013 | 864 | 0.080 |
Why?
|
| India | 2 | 2020 | 143 | 0.080 |
Why?
|
| Azoles | 1 | 2008 | 6 | 0.080 |
Why?
|
| Organoselenium Compounds | 1 | 2008 | 8 | 0.080 |
Why?
|
| Histidine | 2 | 2005 | 53 | 0.070 |
Why?
|
| Cysteine | 2 | 2005 | 68 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 78 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 1601 | 0.070 |
Why?
|
| Gold Sodium Thiomalate | 1 | 2005 | 3 | 0.060 |
Why?
|
| Young Adult | 2 | 2024 | 2804 | 0.050 |
Why?
|
| Adolescent | 2 | 2024 | 3165 | 0.050 |
Why?
|
| Heart | 1 | 2005 | 224 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2024 | 79 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 2008 | 695 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 1056 | 0.050 |
Why?
|
| Oncogenes | 1 | 2022 | 34 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2022 | 126 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2022 | 103 | 0.040 |
Why?
|
| Mercury | 1 | 2001 | 12 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2002 | 85 | 0.040 |
Why?
|
| Cysticercus | 1 | 2020 | 4 | 0.040 |
Why?
|
| Xenopus laevis | 3 | 2008 | 50 | 0.040 |
Why?
|
| Granuloma | 1 | 2020 | 18 | 0.040 |
Why?
|
| Seizures | 1 | 2020 | 49 | 0.040 |
Why?
|
| Afghan Campaign 2001- | 1 | 2019 | 11 | 0.040 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2019 | 11 | 0.040 |
Why?
|
| Tension-Type Headache | 1 | 2018 | 6 | 0.040 |
Why?
|
| Swine Diseases | 1 | 2018 | 13 | 0.040 |
Why?
|
| Brain Edema | 1 | 2018 | 21 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2019 | 69 | 0.040 |
Why?
|
| Gene Expression | 2 | 2015 | 417 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2019 | 273 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 238 | 0.030 |
Why?
|
| Depression | 1 | 2019 | 222 | 0.030 |
Why?
|
| CA-19-9 Antigen | 1 | 2015 | 7 | 0.030 |
Why?
|
| Ovary | 2 | 2008 | 71 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2015 | 62 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2015 | 256 | 0.020 |
Why?
|
| United States | 1 | 2019 | 2201 | 0.020 |
Why?
|
| Zinc | 2 | 2005 | 63 | 0.020 |
Why?
|
| Transcription Factor AP-2 | 2 | 2002 | 5 | 0.020 |
Why?
|
| Xenopus Proteins | 2 | 2002 | 28 | 0.020 |
Why?
|
| Isoindoles | 1 | 2008 | 5 | 0.020 |
Why?
|
| Complement C3c | 1 | 2008 | 3 | 0.020 |
Why?
|
| alpha-Macroglobulins | 1 | 2008 | 4 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2008 | 20 | 0.020 |
Why?
|
| Ceruloplasmin | 1 | 2008 | 10 | 0.020 |
Why?
|
| Trypsin | 1 | 2008 | 24 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 169 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2005 | 43 | 0.020 |
Why?
|
| Xenopus | 1 | 2005 | 28 | 0.020 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2005 | 7 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2005 | 8 | 0.010 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 12 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2005 | 11 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2005 | 19 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2005 | 35 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2005 | 22 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2005 | 122 | 0.010 |
Why?
|
| Lead | 1 | 2005 | 9 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 45 | 0.010 |
Why?
|
| Cadmium | 1 | 2005 | 16 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 242 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 269 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 145 | 0.010 |
Why?
|
| Myocardium | 1 | 2005 | 194 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 581 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 354 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 366 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 286 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2005 | 202 | 0.010 |
Why?
|
| Inflammation | 1 | 2008 | 641 | 0.010 |
Why?
|
| RNA Polymerase III | 1 | 2002 | 5 | 0.010 |
Why?
|
| RNA Polymerase II | 1 | 2002 | 7 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 456 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 284 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 2002 | 11 | 0.010 |
Why?
|
| RNA | 1 | 2002 | 111 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 78 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 133 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2002 | 112 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 208 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 2001 | 11 | 0.010 |
Why?
|
| RNA, Ribosomal, 5S | 1 | 2001 | 4 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2001 | 79 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 404 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 588 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 415 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 376 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 664 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 1600 | 0.010 |
Why?
|